Skip to main content
. 2015 Oct 16;6(41):43529–43539. doi: 10.18632/oncotarget.5984

Figure 3. Changes in the expression of different PGs in LCL and BL cells in different latency stages after 5-aza-dC and TSA treatment.

Figure 3

The intensity of the amplified DNA fragments was normalized to that of GAPDH. Stacked column shows the added sum of PGs measured.